Quality inspectors on Sinovac vaccine production lines use digital technology platforms to monitor the quality and efficiency of vaccine packaging on Sunday. Photos: Li Hao/GT As the world holds high hopes for a vaccine to emerge amid the pandemic, global biological and drug firms are racing on research and development (R&D) efforts and rolling out their products as early as possible, and the participation of Chinese firms in the process provides a golden opportunity for their internationalization, experts said.
A sample of the COVID-19 inactivated vaccine is seen at a vaccine production plant of China National Pharmaceutical Group (Sinopharm) in Beijing, April 10, 2020. [Photo/Xinhua] Egypt has received its second shipment totaling 50,000 doses of anti-coronavirus vaccines developed by Chinese company Sinopharm, local magazine Egypt Today reported.
A worker sorts products at Shijiazhuang Yiling Pharmaceutical Co, which produces the Chinese medicine lianhua qingwen. CHINA DAILY Picking up a box of medicine with her left hand, Zhang Jing checks it carefully with a sample in her right hand to verify what's printed on the box because she's totally lost with Russian.
While doing a good job in its prevention and control of the COVID-19 epidemic, China has also overcome its own difficulties and done everything it can to help the international community and safeguard global health, demonstrating its sense of justice and responsibility, as well as its commitment to the ideas of mutual assistance and international cooperation as a major country through concrete actions. President Xi Jinping learns about Huoshenshan Hospital's operations, treatment of patients, protection for medical workers and scientific research after arriving in Wuhan, March 10, 2020.
Tel：86-10-65368972, 86-10-65369967